Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 11-2012 | 08-2012 | 05-2012 | 02-2012 | 11-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7 | 2 | 7 | 7 | 10 |
| Other current assets | 3 | 0 | 3 | 3 | 10 |
| TOTAL | $10 | $5 | $10 | $10 | $20 |
| Non-Current Assets | |||||
| PPE Net | 10 | 2 | 10 | 10 | N/A |
| TOTAL | $10 | $2 | $10 | $10 | $N/A |
| Total Assets | $20 | $6 | $10 | $10 | $20 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 150 | 143 | 140 | 140 | 140 |
| Accrued Expenses | 90 | 91 | 80 | 70 | 70 |
| TOTAL | $630 | $234 | $240 | $350 | $580 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 360 | 360 | 230 | 0 |
| TOTAL | $N/A | $360 | $360 | $230 | $N/A |
| Total Liabilities | $630 | $594 | $600 | $580 | $580 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,563 | 58,563 | 55,287 | 55,037 | N/A |
| Common Shares | 50 | 58 | 50 | 50 | 50 |
| Retained earnings | -58,380 | N/A | -58,270 | -58,240 | -58,190 |
| Other shareholders' equity | 10 | -58,342 | 0 | 10 | 0 |
| TOTAL | $-610 | $-587 | $-590 | $-560 | $-560 |
| Total Liabilities And Equity | $20 | $6 | $10 | $20 | $20 |